Methicillin resistant staphylococcus AUREUS AMONG PATIENTS PRESENTING WITH DIABETIC FOOT INFECTIONS
Abstract
INTRODUCTION: Diabetic foot infection is defined as a clinical syndrome characterized by the local findings of a site of inflammation or purulence (sometimes with a systemic appearance of sepsis) that occurs in an individual at places below the malleolus with diabetes mellitus. Methicillin antibiotic has been introduced in clinical settings to prevent disease caused by penicillin resistant Staphylococcus species.
OBJECTIVE: To determine the frequency of Methicillin Resistant Staphylococcus aureus in diabetic foot infections.
METHODOLOGY: This study was conducted in the in the Department of Medicine, Lady Reading Hospital Peshawar from (13-01-2017 to 12-01-2018). It had a descriptive cross sectional study design and patients presenting with diabetic foot ulcers were recruited in this study through consecutive sampling and then subjected to detection of MRSA.
RESULTS: The mean age of the patients was 42.2±8.3 years. We had 51.4% males & 48.6% females in. MRSA was detected in 23.6% of diabetic feet.
CONCLUSION: MRSA is quite prevalent in our local population with diabetes mellitus and we suggest focusing more research on these risk factors to take potential preventative measures.
KEY WORDS: Diabetes Mellitus, Diabetic Foot, Staphylococcus Aureus, Methicillin Resistant Staphylococcus Aureus
References
R, Alvi SFD, Fawwad A,Basit A. Antibiogram of Pseudomonas aeroginosa andMethicillin resistant Staphylococcueaureus in patients with diabetes.Pak J Med Sci. 2014;3(04):814-18.
Banashankari GS, Rudresh HK, Harsha AH. Prevalence of gram negative bacteria in Diabetic foot -A Clinico-Microbiological Study. Al Ameen J Med Sci. 2012;5(3):224-32.
Bano S, Tunio SA, Mal S, Jatt AT. Frequency of Methicillin resistant Staphylococcus aureus among Isolates of wound infections from Hyderabad. Sindh Univ Res J. 2012;44(4):683-6.
Ippolito G, Leone S, Lauria FN, Nicastri E, Wenzel RP. Methicillin-resistant Staphylococcus aureus: the superbug. Int J Infec Dis. 2010;17:88-93.
Siddiqui, Rahman A, Bernstein JM. Chronic wound infection: facts and controversies. ClinDermatol. 2010;28:519-26.
Baveja CP, Gumma VN, Jain M, Jha H. Foot ulcer caused by multidrug-resistant Mycobacterium tuberculosis in a diabetic patient. J MedMicrobiol. 2010;59:1247-9.
Percival SL, Thomas J, Linton S, Okel T, Corum L, Slone W. The antimicrobial efficacy of silver on antibiotic-resistant bacteria isolated from burn wounds. Int Wound J. 2011;47:21-9.
Barrett FF, McGehee RF Jr, Finland M. Methicillin-resistant Staphylococcus aureus at Boston City Hospital: bacteriologic and epidemiologic observations. N Engl J Med 1968;279:441-8.
National Nosocomial Infections Surveillance (NNIS) System Report: data summary from January 1992 through June 2002, issued August 2003. Am J Infect Control 2003;31:481-98.
National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992-June 2001, issued August 2001. Am J Infect Control 2001;29:404-21.
Boyce JM. Methicillin-resistant Staphylococcus aureus: detection, epidemiology, and control measures. Infect Dis Clin North Am 1989;3:901-13.
Chaix C, Durand-Zaleski I, Alberti C, Brun-Buisson C. Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA 1999;282:1745-51.
Grundmann H, Hori S, Winter B, Tami A, Austin D. Risk factors for the transmission of methicillin-resistant Staphylococcus aureus in an adult intensive care unit: fitting a model to the data. J Infect Dis 2002;185:481-8.
Barakate MS, Yang Y-X, Foo S-H, . An epidemiological survey of methicillin-resistant Staphylococcus aureus in a tertiary referral hospital. J Hosp Infect 2000;44:19-26.
Jernigan JA, Clemence MA, Scott GA, . Control of methicillin-resistant Staphylococcus aureus at a university hospital: one decade later. Infect Control Hosp Epidemiol 1995;16:686-96.
Cohen SH, Morita MM, Bradford M. A seven-year experience with methicillin-resistant Staphylococcus aureus. Am J Med 1991;91:233-7.
Herwaldt LA. Control of methicillin-resistant Staphylococcus aureus in the hospital setting. Am J Med 1999;106:11-8.
Fishbain JT, Lee JC, Nguyen HD, . Nosocomial transmission of methicillin-resistant Staphylococcus aureus: a blinded study to establish baseline acquisition rates. Infect Control Hosp Epidemiol 2003;24:415-21.
Kenner J, O’Connor T, Piantanida N, . Rates of carriage of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in an outpatient population. Infect Control Hosp Epidemiol 2003;24:439-44.
Sapico FL. Foot infections. In: Finegold SM, George WL, editors. Anaerobic infections in humans. San Diego (USA): Academic Press 1989; 467-484.
Gibbons GW, Eliopoulos GM. Infection of the diabetic foot. In: Kozak GP, Hoar GS, Rowbottam JL, Wheelock FC, Campel D, editors. Management of diabetic foot problems. Philadelphia (USA): WB Saunders; 1984. p. 97-102.
Mowat A, Baum J. Chemotoxis of polymorphnuclear leucocytes from patients with diabetes mellitus. N Engl J Med 1971; 284: 621-627.
Bybee JD, Rogers DE. The phagocytic activity of polymorphnuclear leucocytes obtained from patients with diabetes mellitus. J Lab Clin Med 1964; 64: 1-13.
Tan JS, Anderson JL, Watanakunakorn G, Phair JP. Neutrophil dysfunction in diabetes mellitus. J Lab Clin Med 1975; 85: 26-33.
Goldstein EJ, Citron DM, Nesbit CA. Diabetic foot infections. Bacteriology and activity 10 oral antimicrobial agents against bacteria isolated from consecutive cases. Diabetes Care 1996; 19: 638-641.
Kajetan M, Konkoly TM, Jermendy G. Experience with microbiological studies of the diabetic foot. Orv Hetil 1995;136: 2161-2164.
Tentolouris N, Jude E, Smirnof I, Knowles E, Boulton AJM. Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic. Diabet Med 1999; 16: 767–771.
Game F, Jeffcoate W. MRSA and osteomyelitis of the foot in diabetes. Diabet Med 2004; 21(suppl 4): 16–19.
Reiber G, Lipsky B, Gibbons G. The burden of diabetic foot ulcers. Am J Surg 1998; 176(suppl 2A): 5–10.
Hartemann-Heurtier A, Robert J, Jacqueminet S et al. Diabetic foot ulcer and multidrug-resistant organisms: risk factors and impact. Diabet Med 2004; 21: 710–715.
